Loading
Colin Farlow

Colin Farlow

Co-Founder and CEO, Serotiny
Colin Farlow cofounded Serotiny, a Bay Area biotech focused on designing therapeutic multi-domain proteins for gene and cell therapies. Colin earned his JD from University of Wisconsin Law School and started Serotiny to apply scalable technologies to gene and cell therapy discovery. Serotiny strategically partnered with leading biotech and Pharma, including Johnson & Johnson, which led to the company’s acquisition of Serotiny.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS